EPISODE · Mar 5, 2025 · 1H 19M
Rewriting Genetic Medicine with Epigenetic Editing | Dr Catherine Stehman-Breen, former CEO of Chroma Medicine
from Nucleate Podcast · host Catherine Stehman-Breen, Sam Kessel, Anastasia Janas
Follow us on https://signal.nucleate.xyz/04:14 - Dr. Stehman-Breen discusses her decision to pursue a career in medicine.05:49 - Dr. Stehman-Breen explains her specialty choice in internal medicine and nephrology.08:09 - Skills and mindset that prepared Catherine for a career in industry.13:53 - The critical impact that physicians can have in biotech19:03 - Overview of epigenetic editing and Chroma Medicine's approach.0:28:22 - Early days of building Chroma Medicine from the ground up.0:38:22 - Merger with NVelop Therapeutics and future directions.0:44:22 - Dr. Stehman-Breen offers advice for entrepreneurs and the value of an Entrepreneur in Residence role.0:49:22 - Balancing her demanding career with personal hobbies and interests.
What this episode covers
Dr. Catherine Stehman-Breen discusses her career journey, from her early interest in medicine to her roles at pharmaceutical companies like Amgen. The highlight is her time as CEO of Chroma Medicine, a biotech focused on epigenetic editing.
NOW PLAYING
Rewriting Genetic Medicine with Epigenetic Editing | Dr Catherine Stehman-Breen, former CEO of Chroma Medicine
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Jan 2, 2026 ·47m
Dec 21, 2025 ·46m